Autolus Therapeutics (AUTL) Stock Aims For Cancer Breakthrough
Wasim Omar
September 16, 2022
Autolus Therapeutics plc (NASDAQ: AUTL) is down by nearly 60% in the last 12 months. It dabbles in a highly sensitive area, of cancer research,